Skip to content
  • News & Events
    • Press & Media
  • Culture
    • Careers
  • Partnering
  • Investors
  • Contact
Menu
  • News & Events
    • Press & Media
  • Culture
    • Careers
  • Partnering
  • Investors
  • Contact
  • Science
    • Barriers to Treatment in the Liver
    • Barriers to Treatment in the Pancreas
    • Overcoming Immunosuppression
    • Overcoming Intratumoral Pressure
    • Publications & Presentations
  • Platform
    • Drug Delivery Technology
  • Pipeline
    • Candidate SD-101
  • Clinical Trials
  • For Patients
  • About
Menu
  • Science
    • Barriers to Treatment in the Liver
    • Barriers to Treatment in the Pancreas
    • Overcoming Immunosuppression
    • Overcoming Intratumoral Pressure
    • Publications & Presentations
  • Platform
    • Drug Delivery Technology
  • Pipeline
    • Candidate SD-101
  • Clinical Trials
  • For Patients
  • About
Menu
  • Science
    • Barriers to Treatment in the Liver
    • Barriers to Treatment in the Pancreas
    • Overcoming Immunosuppression
    • Overcoming Intratumoral Pressure
    • Publications & Presentations
  • Platform
    • Drug Delivery Technology
  • Pipeline
    • Candidate SD-101
  • Clinical Trials
  • For Patients
  • About
  • News & Events
    • Press & Media
  • Culture
    • Careers
  • Partnering
  • Investors
  • Contact

News & Events

Stay current with the latest news from TriSalus and connect with us at events and conferences.

Recent Press Releases

TriSalus Life Sciences to Showcase Treatment Platform and Present Pressure-Enabled Regional Immuno-Oncology (PERIO) Data at the Society of Interventional Radiology’s 2023 Annual Scientific Meeting

February 28, 2023

TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business

February 21, 2023

TriSalus Life Sciences Posts Updated Investor Presentation Highlighting Additional Phase 1 and 1b Clinical Data for Pressure-Enabled Regional Immuno-Oncology™-01 and -02 Studies

February 16, 2023
VIEW MORE

Events

March 4-9, 2023

Society of Interventional Radiology (SIR) 2023 Annual Scientific Meeting

The SIR Annual Scientific Meeting brings together experts from across the interventional radiology community to discuss advancements in research and clinical practice. As a proud member of SIR’s Corporate Ambassador Program, TriSalus hosted several educational events and presented multiple research abstracts at this year’s conference.

January 19-23, 2023

SIO 2023 Annual Scientific Meeting​

During the Society of Interventional Oncology (SIO) 2023 Annual Scientific Meeting, TriSalus Chief Medical Officer, Dr. Steven Katz, along with Scientific Advisory Board Members Drs. Alexander Kim and Rahul Sheth, led a symposium discussing updates from the PERIO™ clinical trials. TriSalus Senior Director of Pharmacology and Therapeutics, Thomas Hullinger, presented pre-clinical data on the delivery of investigational SD-101 into pig liver tumors via Pressure-Enabled Drug Delivery™ (PEDD™) compared to a standard end-hole catheter. 

January 19-21, 2023

ASCO Gastrointestinal Cancers Symposium​

At the 2023 ASCO Gastrointestinal (GI) Cancers Symposium, pre-clinical research, conducted in partnership with the UC San Diego Moores Cancer Center, was presented. The poster presentation demonstrated the benefits of Pressure-Enabled Drug Delivery™ (PEDD™) of an investigational TLR9 agonist in combination with checkpoint inhibitor therapy for the treatment of pancreatic tumors in murine models.

Twitter

Find TriSalus on Twitter.

TriSalusLifeSci
TriSalusLifeSci
@TriSalusLifeSci

#TrialTuesday: The PERIO-02 clinical trial is evaluating our #immunotherapy platform in patients liv...

Read More »
02:01 PM · 28 Mar 2023
2 Retweet 2 likes
TriSalusLifeSci
TriSalusLifeSci
@TriSalusLifeSci

#TeamTriSalus is united by our common purpose to transform the lives of patients living with #liver ...

Read More »
03:01 PM · 23 Mar 2023
1 Retweet 2 likes
TriSalusLifeSci
TriSalusLifeSci
@TriSalusLifeSci

The PERIO-01 #clinicaltrial is studying the delivery of an investigational #immunotherapy, SD-101, v...

Read More »
02:01 PM · 21 Mar 2023
2 Retweet 3 likes
© 2023 TriSalus Life Sciences, Inc. All rights reserved
  • Privacy Policy
  • Compliance
  • Terms of Use
Linkedin Twitter
Linkedin Twitter
© 2023 TriSalus Life Sciences, Inc.
All rights reserved
  • Privacy Policy
  • Compliance
  • Terms of Use

IMPORTANT NOTICE

You are now leaving the Trisalus life Sciences corporate website.

We encourage you to read and evaluate terms of use, privacy, security and other similar policies of the destination site as they may differ from TriSalus’ standards.

Third Party Sites

TriSalus assumes no responsibility nor does it control, endorse or guarantee any aspect of your use of any third party sites. Additionally, the presence of this link does not imply the third party site’s endorsement of TriSalus or this website.

Thank you for visiting our site.

YES
CANCEL